Company / Capital Expenditures
PRECIGEN, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.0M
FY2025
5-year range
$1.5M / $8.6M
FY2021-FY2025
Trend
-76.8%
vs FY2024
Sector context
#96 of 194
Health Care
What the data says
At $2M, PRECIGEN, INC.'s capital expenditures ranks #96 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2023 to $47M in FY2019.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -45.5%.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -26.0%
- 5-Year CAGR
- -45.5%
- 10-Year CAGR
- -
Sector benchmark
#96 of 194 in Health CareTop 49% of 194This company $2.0M Sector average $117.5M
▼
-98.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -45.5%, indicating a declining trend.
- In FY2025, capital expenditures decreased 76.8% year-over-year.
- Ranks #96 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -14.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | -76.8% |
| FY2024 | $8.6M | +458.9% |
| FY2023 | $1.5M | -68.8% |
| FY2022 | $4.9M | -32.1% |
| FY2021 | $7.2M | -82.6% |
| FY2020 | $41.6M | -10.9% |
| FY2019 | $46.7M | +12.2% |
| FY2018 | $41.6M | -10.9% |
| FY2017 | $46.7M | +47.5% |
| FY2016 | $31.6M | +1971.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026